Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ECE1 | P42892 | 2/20 | 0.32 |
| ▸ | FDPS | P14324 | 1/20 | 0.31 |
| ▸ | MMP1 | P03956 | 1/20 | 0.30 |
| ▸ | MMP2 | P08253 | 1/20 | 0.30 |
| ▸ | MMP3 | P08254 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29489578 | 0.82 | KDM4E (0.31) | ECE1 | |
| SCHEMBL26107407 | 0.80 | CA2 (0.35) | MMP1MMP2MMP3 | |
| SCHEMBL21184231 | 0.79 | ECE1 (0.31) | ECE1FDPS | |
| SCHEMBL3392036 | 0.79 | ALDH1A1 (0.38) | ECE1 | |
| SCHEMBL7100178 | 0.79 | TDP1 (0.32) | — | |
| SCHEMBL143938 | 0.78 | SLC22A6 (0.38) | — | |
| SCHEMBL514097 | 0.78 | ALDH1A1 (0.31) | MMP1MMP2MMP3 | |
| SCHEMBL10045293 | 0.78 | ALDH1A1 (0.48) | MMP1MMP2MMP3 | |
| SCHEMBL23288379 | 0.77 | ALDH1A1 (0.33) | — | |
| SCHEMBL21315733 | 0.76 | BHMT (0.36) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040142981-A1 | Antibacterial benzoic acid derivatives | PHARMACIA & UPJOHN COMPANY | 2004-07-22 | — | — | US | claimed |
| US-20040110802-A1 | Antibacterial benzoic acid derivatives | PHARMACIA & UPJOHN COMPANY | 2004-06-10 | — | — | US | claimed |
| WO-2004018428-A1 | ANTIBACTERIAL BENZOIC ACID DERIVATIVES | PHARMACIA & UPJOHN COMPANY LLC (US) | 2004-03-04 | — | — | WO | claimed |
| WO-2004018461-A2 | ANTIBACTERIAL BENZOIC ACID DERIVATIVES | PHARMACIA & UPJOHN COMPANY LLC (US) | 2004-03-04 | — | — | WO | claimed |
| EP-0039032-A2 | Use of 3,5,5-trimethylhexanoic acid amides as perfuming agents and compositions containing them | Henkel Kommanditgesellschaft auf Aktien (DE) | 1981-11-04 | — | — | EP | claimed |
| EP-4565344-A1 | SELECTIVE EXTRACTION OF RHODIUM FROM HYDROCHLORIC ACID SOLUTIONS COMPRISING RHODIUM AND IRIDIUM | Johnson Matthey Public Limited Company (GB) | 2025-06-11 | — | — | EP | disclosed |
| WO-2024028564-A1 | SELECTIVE EXTRACTION OF RHODIUM FROM HYDROCHLORIC ACID SOLUTIONS COMPRISING RHODIUM AND IRIDIUM | JOHNSON MATTHEY PUBLIC LIMITED COMPANY (GB) | 2024-02-08 | — | — | WO | disclosed |
| EP-3277084-B1 | COMPOSITION COMPRISING A PESTICIDE AND ISONONANOIC ACID N,N-DIMETHYL AMIDE | BASF SE (DE) | 2022-01-12 | — | — | EP | disclosed |
| WO-2013170934-A1 | PARTICLES FOR ELECTROPHORETIC DISPLAYS | MERCK PATENT GMBH (DE) | 2013-11-21 | — | — | WO | disclosed |
| EP-2379687-B1 | WATER-BASED HYDRAULIC FLUIDS COMPRISING DITHIO-DI(ARYL CARBOLIC ACIDS) | CLARIANT FINANCE BVI LTD (VG) | 2013-04-24 | — | — | EP | disclosed |
| US-8242103-B2 | Sulphamides for treatment of cancer | MERCK SHARP & DOHME LIMITED (GB) | 2012-08-14 | — | — | US | disclosed |
| US-20090197904-A1 | Sulphamides for Treatment of Cancer | MERCK SHARP & DOHME (UK) LIMITED (GB) | 2009-08-06 | — | — | US | disclosed |
| WO-2002036555-A1 | SULFAMIDES AS GAMMA-SECRETASE INHIBITORS | MERCK SHARP & DOHME LIMITED (GB) | 2002-05-10 | — | — | WO | disclosed |
| US-6333432-B1 | CONTROLLING PHYTOPATHOGENS | DOW AGROSCIENCES LLC | 2001-12-25 | — | — | US | disclosed |
| US-5187053-A | Storage stability | FUJI PHOTO FILM CO., LTD. (JP) | 1993-02-16 | — | — | US | disclosed |
| US-5037733-A | High speed, storage stable photographic films and papers, surface bromination of silver halide grains, cyanine dyes | FUJI PHOTO FILM CO., LTD. (JP) | 1991-08-06 | — | — | US | disclosed |
| US-4770991-A | HIGH SPEED GIVING HIGH CONTRAST AND HIGH MAXIMUM DENSITY IMAGES | FUJI PHOTO FILM CO., LTD. (JP) | 1988-09-13 | — | — | US | disclosed |
| EP-0039032-A2 | Use of 3,5,5-trimethylhexanoic acid amides as perfuming agents and compositions containing them | Henkel Kommanditgesellschaft auf Aktien (DE) | 1981-11-04 | — | — | EP | disclosed |
| EP-0039032-A2 | Use of 3,5,5-trimethylhexanoic acid amides as perfuming agents and compositions containing them | Henkel Kommanditgesellschaft auf Aktien (DE) | 1981-11-04 | — | — | EP | disclosed |
| EP-0039032-A2 | Use of 3,5,5-trimethylhexanoic acid amides as perfuming agents and compositions containing them | Henkel Kommanditgesellschaft auf Aktien (DE) | 1981-11-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090197904-A1 | Sulphamides for Treatment of Cancer | SDHA, SDHB, BRDT | ECE1 3448/4885FDPS 370/4885MMP1 4200/4885 |
| US-20040142981-A1 | Antibacterial benzoic acid derivatives | GABRD, PHB1, GABBR1 | ECE1 1198/4885FDPS 1684/4885MMP1 1708/4885 |
| US-20040110802-A1 | Antibacterial benzoic acid derivatives | GABRD, GABBR1, GABRA1 | ECE1 1298/4885FDPS 2615/4885MMP1 1566/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.